Hereditary Spastic Paraplegia in Alberta: Lessons from a Well‐Defined Cohort Including the Indigenous Population
Movement Disorders Clinical Practice · 2025
DOI: 10.1002/mdc3.70115 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Ekhlas Assaedi und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Taibah University, Medina, Saudi Arabia. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
Hereditary spastic paraplegias (HSP) are rare disorders sharing common features of leg spasticity with gait impairment. Simple and complex forms are recognized; over 50% of cases remain unsolved genetically. Little is known about the genetics of HSP among Indigenous Peoples.
Objectives
To describe clinical, radiological, and genetic features of HSP in Alberta, Canada, and evaluate genetic variability among ethnic groups.
Methods
Patients with HSP were recruited between 2012 and 2021, and enrolled in an observational study. Genetic testing through research and/or clinical laboratories was performed.
Results
100 patients from 86 Albertan families were enrolled. Overall prevalence was 2.3 per 100,000, with 2.8 per 100,000 in the Indigenous population. Forty‐eight families (56%) were found to have pathogenic variants in 17 genes, including SPAST (29.2%), SPG7 (20.8%), SPG11 (8.3%), CAPN1 (6.3%), and SACS (6.3%). 58% of families had complex HSP. 36/66 White (European) families, 5/8 Indigenous families, 4/8 Asian families and 2/3 Middle Eastern families were confirmed with a genetic diagnosis. One Black (African) family was enrolled and tested positive for PI4KA . In Indigenous families, pathogenic variants were found in CTNNB1 , SACS , SPG7 , and SYNE1 . Abnormalities of brain MRI were more frequently observed in patients with SACS , SPG7 , SPG11 , and ANO10 .
Conclusions
This study details findings in HSP patients in Alberta and is the first study to examine prevalence and types of HSP in the Indigenous Peoples of Alberta. It highlights the need for familiarity with the phenotypes and genotypes in the different ethnic populations in Alberta.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, Taibah University, Medina, Saudi Arabia.
- Department of Medical Genetics, University of Calgary, Calgary, AL, Canada.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
- Department of Clinical Neurosciences and Critical Care Medicine, University of Calgary, Calgary, AL, Canada.
- Department of Medicine (Neurology), University of Alberta, Edmonton, AL, Canada.
ORCID-Profile: Ekhlas Assaedi, Ziv Gan-Or, Guy Rouleau
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Assaedi, E., Ashtiani, S., Estiar, M. A., Gan-Or, Z., McKenzie, E. D., Shetty, A., Rouleau, G., & Suchowersky, O. (2025). Hereditary Spastic Paraplegia in Alberta: Lessons from a Well‐Defined Cohort Including the Indigenous Population. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70115
Vancouver
Assaedi E, Ashtiani S, Estiar MA, Gan-Or Z, McKenzie ED, Shetty A, et al. Hereditary Spastic Paraplegia in Alberta: Lessons from a Well‐Defined Cohort Including the Indigenous Population. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70115
BibTeX
@article{Assaedi2025,
author = {Assaedi, Ekhlas and Ashtiani, Setareh and Estiar, Mehrdad A and Gan-Or, Ziv and McKenzie, Erica D and Shetty, Aakash and Rouleau, Guy and Suchowersky, Oksana},
title = {Hereditary Spastic Paraplegia in Alberta: Lessons from a Well‐Defined Cohort Including the Indigenous Population},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.70115}
}
EUVIMED